Britain’s most promising businesses are being held back by surging employment costs and persistent difficulties attracting skilled workers, new research has found. A survey of 423 leaders of high-growth companies by Enterprise
Harvey, the legal artificial intelligence company, has closed a $550 million funding round at a $15.5 billion valuation, co-led by Diffusion and Lightspeed. The raise brings Harvey’s total funding to more than
More
Artificial intelligence-related concerns have triggered fresh turbulence across technology markets, sending Nasdaq futures lower as investors reassess valuations in the sector. The selloff reflects growing unease among market participants about the sustainability
More
London’s benchmark index opened Monday’s session on the front foot, with energy stocks leading gains as crude oil prices climbed sharply across global markets. The FTSE 100 drew support from a broad
More
Boardroom tensions at Big Technologies have flared once more after mediated settlement discussions with founder Sara Murray ended without any agreement. The AIM-listed electronic monitoring group confirmed on Monday that legal proceedings
More
On August 26, 2026, President Trump signed Executive Order 14421, invoking the International Emergency Economic Powers Act and National Emergencies Act to address foreign-produced equipment in the U.S. bulk-power system. The order
More
Frank Ramos, a partner at Goldberg Segalla in Miami, argues that knowing how to use AI is simply not a career plan for young lawyers entering the profession today. Neither is the
More
HSBC Holdings (LSE: HSBA) has delivered one of the most remarkable performances of any FTSE 100 stock over the past five years, rising a staggering 330% with dividends on top. The bank
More
Investors looking to protect their portfolios should focus on companies with strong fundamentals, reliable cash flows, and durable competitive advantages that hold up during volatile periods. Market sell-offs can arrive without warning,
More
Andy Burnham faces mounting pressure from the hospitality industry to follow through on his pre-election support for a significant VAT reduction. More than 800 pubs, restaurants, hotels and hospitality businesses have signed
More
AstraZeneca (AZN) and Daiichi Sankyo are facing a significant obstacle in their push to expand the use of cancer drug Enhertu into a key new treatment setting. The two pharmaceutical giants have
More